Medical

Akanda closes acquisition on Bophelo and CanMart

The move “marks a major step towards Akanda’s establishment as an international medical cannabis company”.

Akanda closes acquisition on Bophelo and CanMart

Akanda Corp has completed its acquisition of Bophelo and CanMart – creating an international medical cannabis company.

After readying itself for a senior exchange listing, Akanda has completed the acquisition of parent company Halo Collective‘s subsidiaries Bophelo Bio Science & Wellness Ltd. and CanMart Ltd..

The closing of the acquisition will allow Akanda to reach international markets through multiple channels, including CanMart – which is a UK-based approved pharmaceutical importer and distributor which supplies pharmacies and clinics within the country.

Read more: Akanda CEO discusses ESG and disruption in European cannabis market

CEO and director of Akanda, Tej Virk, commented: “Today marks a major step towards Akanda’s establishment as an international medical cannabis company helping patients around the world lead better lives.

“At our GACP-certified Bophelo campus in Lesotho with access to 200 hectares of land, we’re leveraging the country’s ideal growing conditions and exceptional talent pool to produce medical cannabis of the highest quality at an extremely competitive cost.

“We believe we have one of the industry’s best platforms to meet patient needs and gain market share in the rapidly growing international cannabis market.”

Under the agreement, Akanda has purchased 100 per cent of the issued and outstanding shares of Canahealth Limited, a company which holds the Bophelo and CanMart assets, from Halo in exchange for 13,129,212 common shares in the capital of Akanda. It has also seen Akanda issue a secured convertible debenture to Halo in the principal amount of £~4.88m (US$6.6m) in exchange for acquiring all outstanding indebtedness owed by Bophelo and CanMart to Halo, which bears an interest rate of 1 per cent annually.

Halo Collective Inc. recently announced that it had entered into an agreement with Akanda in connection with the announced sale of its international assets. Prior to this,  Halo completed its internal reorganisation, with Bophelo and CanMart becoming wholly-owned subsidiaries of Cannaheath.

[activecampaign form=31]

Topicscannabis industryinternationalmedical cannabis

Stephanie Price

Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on "Medical Cannabis Explained".

More from Stephanie

Spotted an error, or have a tip? Contact the newsroom.

Up next · Medical

German Cannabis Pioneer SynBiotic SE Files For Insolvency

Ben Stevens · 28 October 2026

More